F-star Therapeutics, Inc.
FSTX
Price:
$7.12
Market Cap:
$156.51M
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-s...[Read more]
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
FSTX
PE Ratio
[-3.89]
ROE
[-44.74%]
Current Ratio
[6.98]
Dividend Yield
[0%]
Enterprise Value
[91.20M]
Dividend History
The ROE as of November 2025 (TTM) for F-star Therapeutics, Inc. (FSTX) is -44.74%
According to F-star Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -44.74%. This represents a change of 163.14% compared to the average of -17.00% of the last 4 quarters.
F-star Therapeutics, Inc. (FSTX) Historical ROE (quarterly & annually)
How has FSTX ROE performed in the past?
The mean historical ROE of F-star Therapeutics, Inc. over the last ten years is -97.35%. The current -44.74% ROE has changed -54.04% with respect to the historical average. Over the past ten years (40 quarters), FSTX's ROE was at its highest in in the December 2021 quarter at 4.89%. The ROE was at its lowest in in the March 2016 quarter at -85.70%.
Average
-97.35%
Median
-69.62%
Minimum
-269.60%
Maximum
-32.30%
F-star Therapeutics, Inc. (FSTX) ROE by Quarter and Year
Discovering the peaks and valleys of F-star Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 558.96%
Maximum Annual ROE = -32.30%
Minimum Annual Increase = -77.90%
Minimum Annual ROE = -269.60%
| Year | ROE | Change |
|---|---|---|
| 2021 | -32.30% | -45.80% |
| 2020 | -59.59% | -77.90% |
| 2019 | -269.60% | 558.96% |
| 2018 | -40.91% | -48.64% |
| 2017 | -79.66% | -21.94% |
F-star Therapeutics, Inc. (FSTX) Average ROE
How has FSTX ROE performed in the past?
The current ROE of F-star Therapeutics, Inc. (FSTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-120.49%
5-year avg
-96.41%
10-year avg
-97.35%
F-star Therapeutics, Inc. (FSTX) ROE vs. Peers
How is FSTX’s ROE compared to its peers?
F-star Therapeutics, Inc.’s ROE is greater than Theseus Pharmaceuticals, Inc. (-20.74%), less than Selecta Biosciences, Inc. (754.65%), greater than eXoZymes, Inc. (-127.54%), greater than Pardes Biosciences, Inc. (-41.86%), greater than aTyr Pharma, Inc. (-100.11%), greater than Vaccitech plc (-70.19%), greater than NGM Biopharmaceuticals, Inc. (-69.76%), less than Sesen Bio, Inc. (86.43%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than Decibel Therapeutics, Inc. (-56.38%),
| Company | ROE | Market cap |
|---|---|---|
| -20.74% | $181.50M | |
| 754.65% | $135.20M | |
| -127.54% | $125.81M | |
| -41.86% | $135.19M | |
| -100.11% | $81.11M | |
| -70.19% | $192.73M | |
| -69.76% | $128.53M | |
| 86.43% | $127.96M | |
| 42.54% | $127.83M | |
| -56.38% | $123.37M |
Build a custom stock screener for F-star Therapeutics, Inc. (FSTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like F-star Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
F-star Therapeutics, Inc. (FSTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like F-star Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is F-star Therapeutics, Inc.'s ROE?
How is the ROE calculated for F-star Therapeutics, Inc. (FSTX)?
What is the highest ROE for F-star Therapeutics, Inc. (FSTX)?
What is the 3-year average ROE for F-star Therapeutics, Inc. (FSTX)?
What is the 5-year average ROE for F-star Therapeutics, Inc. (FSTX)?
How does the current ROE for F-star Therapeutics, Inc. (FSTX) compare to its historical average?